Acute Respiratory Failure & Acute Respiratory Distress Syndrome

Learning Objectives

• Implications and clinical significance of Acute Respiratory Failure (ARF) and Acute Respiratory Distress Syndrome (ARDS)

• Prompt recognition of ARF and ARDS at the bedside / in the ICU

• Understand underlying mechanisms precipitating both disorders

• Nursing considerations & interventions for safe, outcome-focused care

• Be able to distinguish ARF vs. ARDS clinically and pathophysiologically

• Develop evidence-based management plans for each condition

Acute Respiratory Failure (ARF)

Definition & General Overview

• Inadequate gas exchange resulting in one or both of the following:

  • Hypoxemia → \text{PaO}_2 < 60\;\text{mmHg} on $\ge 60\%$ FiO2

  • Hypercapnia → \text{PaCO}_2 > 45\;\text{mmHg} with accompanying acidemia \bigl(pH < 7.35\bigr)

• Onset may be sudden (minutes–hours) or insidious (days)

• Classifications

  • Hypoxemic (oxygenation failure)

  • Hypercapnic (ventilatory failure)

  • Mixed picture is common in the real world

Types & Etiologies

Hypoxemic Causes

• Bronchiectasis, Hepatopulmonary syndrome, Pneumonia, Pneumothorax, Pulmonary embolism (PE), Pulmonary fibrosis, Smoke inhalation

Hypercapnic Causes

• COPD, Cystic fibrosis, Hypoventilation syndrome, Kyphoscoliosis, Trauma, Spinal cord injury (SCI), Guillain–Barré syndrome, Multiple sclerosis

Shared (either hypoxemic or hypercapnic)

• ARDS, Asthma, Chronic bronchitis, Emphysema, Cardiogenic / non-cardiogenic pulmonary edema

Hypoxemic ARF — Pathophysiology & Mechanisms

• Four hallmark mechanisms; more than one usually co-exists

  1. Ventilation/Perfusion (V/Q) mismatch**

  2. Shunt**

  3. Diffusion limitation

  4. Alveolar hypoventilation

  • *Most frequent mechanisms

1. Ventilation/Perfusion (V/Q) Mismatch

• Normal lung: $V \approx Q \; \Rightarrow \; V/Q \approx 1$

• Causes ↓V or ↑Q: secretions (pneumonia), atelectasis, PE (↓Q), pain-limited expansion

• Nursing priorities: titrate $\text{O}_2$, serial ABGs, SpO2 trending, focused chest exam, monitor LOC

2. Shunt

• Extreme V/Q mismatch where blood exits the heart without any gas exchange

  • Anatomic: e.g., ventricular septal defect

  • Capillary (intrapulmonary): alveoli filled with fluid / exudate (pneumonia, ARDS)

• Typically refractory to conventional $\text{O}_2$; requires high FiO2 or mechanical ventilation with PEEP

3. Diffusion Limitation

• Thickened / fibrotic A–C membrane → slower $\text{O}_2$ diffusion

• Etiologies: pulmonary fibrosis, interstitial lung disease, ARDS

• Hallmark: exercise-induced hypoxemia that is not present at rest (worsens with exercise)

4. Alveolar Hypoventilation

• Global ↓ ventilation → hypercapnia and hypoxemia with ↑ dead space

• Causes: CNS depression, chest-wall restriction, acute asthma, restrictive lung disease

Synergistic Mechanisms

• Example — Pneumonia: inflammatory exudate blocks airways → V/Q mismatch and floods alveoli → shunt

Hypercapnic ARF — Etiology & Mechanisms

• “Ventilatory failure” → lungs cannot expel $\text{CO}_2$ efficiently

• Four primary pathways:

  1. CNS depression / injury (opioid overdose, TBI)

  2. Neuromuscular disorders (Guillain–Barré, MS, pesticide exposure)

  3. Chest-wall abnormalities (morbid obesity, flail chest $\ge 3$ ribs fractured in $\ge 2$ places, severe kyphosis)

  4. Airway–alveolar diseases (COPD, asthma, cystic fibrosis)

Clinical Manifestations (Hypoxemic vs. Hypercapnic)

• Highly variable; onset = minutes → days

• Early hypoxemia: altered LOC, tachycardia, mild restlessness, pallor, dyspnea on exertion, subtle ↑ work of breathing (WOB)

• Early hypercapnia: morning headache, flushed skin, mild disorientation

• Progressive signs (either type):

  • Severe dyspnea, nasal flaring, retractions, paradoxical breathing, diaphoresis, cyanosis, use of accessory muscles, seizures/coma

Diagnostic Work-up

• Chest X-ray (infiltrates? pneumothorax? mass?)

• ABG (trend PaO2, PaCO2, pH, HCO3−) → checks oxygenation and ventilation status

• Labs: CBC (infection), CMP (electrolyte imbalances), cultures (blood/sputum), 12-lead ECG (r/o cardiac origin), D-dimer → CT angiography or V/Q scan if PE suspected

• If on mechanical ventilation → continuous EtCO2 trending

Nursing & Interprofessional Management

Assessment Focus

• (Full Respiratory Assessment): Airway patency, respiratory muscle fatigue, tissue perfusion, acid–base status

• History: precipitating illness, meds (sedatives, opioids), surgeries

• Objective: VS, breath sounds, SpO2 trends, mental status, hemodynamics, diagnostics

Priority Goals

1. Maintain patent airway (independently preferred)

2. Restore baseline breathing pattern & WOB4

3. Effective clearance of secretions

4. Normalize ABGs or return to patient’s baseline

5. Auscultatory improvement

6. Hemodynamic stability (MAP $\ge 65\;\text{mmHg}$)

Implementation Strategies

• Respiratory therapies

  • Administer $\text{O}_2$ (nasal cannula → high-flow → NIPPV/BiPAP) matched to severity

  • Mobilize secretions: positioning (HOB $\ge 30^{\circ}$, “good lung down”), C&DB, chest physiotherapy, suction, humidification, hydration

  • Positive-pressure ventilation if persistent distress

• Pharmacology

  • Bronchodilators (albuterol) & corticosteroids → ↓ bronchospasm / inflammation

  • Diuretics, morphine, nitroglycerin → address pulmonary congestion

  • IV antibiotics per culture & CXR findings for infection

  • Anxiolytics / opioids (titrate; avoid hypoventilation in CO2 retainers)

• Nutrition

  • Hyper-metabolic; target caloric intake within 24–48 h

  • Enteral feeding preferred; consult dietician for protein & fluid goals

Acute Respiratory Distress Syndrome (ARDS)

Definition & Epidemiology

• Sudden, progressive form of ARF with non-cardiogenic pulmonary edema

• Incidence: ≈ $10\%$ of adult ICU admissions (≈200 000 cases/yr in US)

• Mortality still >$35\%$; main precipitant = sepsis / multiple-organ dysfunction syndrome (MODS)

• Classified using Berlin System

Pathophysiology — Three Overlapping Phases

1. Exudative (24–72 h post-insult; lasts 7–10 d)

• Endothelial / epithelial damage → leaky capillaries → interstitial & alveolar edema

• Develop V/Q mismatch and shunt; alveoli fluid-filled → refractory hypoxemia

2. Proliferative (day 7–14)

• Massive influx of neutrophils, macrophages, fibroblasts

• Fibroproliferation → ↓ lung compliance, ↑ pulmonary vascular resistance, pulmonary HTN

• Ongoing V/Q mismatch, shunt, diffusion limitation

• Phase ends with either resolution or transition to fibrosis

3. Fibrotic (after day 14; not universal)

• Lung “remodeling” with collagen deposition → diffuse scarring (hardened lungs cannot expand during respiration)

• Marked ↓ compliance & surface area → chronic severe hypoxemia; poor prognosis

Clinical Manifestations**KNOW EARLY AND LATE

• Early (subtle/mild): dyspnea, tachypnea, dry cough periodically, restlessness; fine crackles; ABG shows mild hypoxemia + respiratory alkalosis; CXR may be normal or show hazy infiltrates

• Late (progressive & severe): profound dyspnea, cyanosis, intercostal/suprasternal retractions, tachycardia, diaphoresis, altered LOC

  • Hallmark: refractory hypoxemia → \text{PaO}2/\text{FiO}2 < 300 despite increasing FiO2

  • “White-out” bilateral infiltrates on CXR

  • ABG: severe hypoxemia, hypercapnia, metabolic (lactic) acidosis

Diagnostic Studies

• Serial ABGs, CXR, pulmonary function tests (↓ FRC, ↓ compliance)

• Hemodynamics with PA catheter: ↑ PA pressures, normal/low PCWP rules out cardiogenic edema; ↓ SvO2 suggests poor oxygen extraction

Complications

• Abnormal long-term lung function (restrictive defect may persist >12 mo)

• Ventilator-associated pneumonia (VAP)

• Barotrauma (pneumothorax, subcutaneous emphysema) from high VT/PEEP

• Stress GI ulcers (→ PPIs, sucralfate; early enteral feeds)

• Venous thromboembolism (VTE) → SCDs, LMWH, early mobility

• Acute kidney injury (hypotension, nephrotoxic drugs)

• Psychosocial sequelae: PTSD, depression, cognitive deficits

Interprofessional Management & Nursing Care

Target Goals

• Immediate: \text{PaO}_2 > 60\;\text{mmHg}, SaO2 > 90\%; acid-base correction

• Long-term: return to pre-illness oxygenation, clear breath sounds, resolution of precipitating factor(s)

Respiratory Therapies

• Mechanical ventilation — lung-protective strategy

  • Low tidal volume: $VT \approx 4–6\;\text{mL\,kg}^{-1}$ predicted body weight (limits volutrauma)

  • Permissive hypercapnia accepted: $\text{PaCO}_2 \le 60\;\text{mmHg}$; keep pH > $7.25$

  • PEEP: maintains alveolar recruitment, ↑ FRC, ↓ shunt (careful of barotrauma & ↓ CO)

• Prone positioning (12–16 h/day): improves V/Q by recruiting dorsal lung units; monitor pressure points & ETT stability

• Rescue modalities: ECMO in refractory cases; high cost & resource intensive

Supportive Measures

• Analgesia (fentanyl) & sedation (propofol, dexmedetomidine); titrate to RASS/ICU protocols

• Neuromuscular blocking agents (vecuronium, cisatracurium) during severe early phase to optimize ventilator synchrony

• Hemodynamic optimization: maintain MAP $\ge 65$ using vasopressors (norepinephrine, vasopressin) or inotropes (dobutamine) ** KNOW

• Conservative fluid strategy (“keep on dry side”): balance between avoiding pulmonary edema yet ensuring organ perfusion

• Nutrition: initiate enteral feeds within 24–48 h; adequate protein prevents respiratory muscle wasting

Evaluation Criteria

• Progressive ↑ PaO2/FiO2 ratio

• ↓ FiO2 & PEEP requirement over time

• Stable hemodynamics without escalating vasopressors

• Renal function stable; no new organ failures

Review / Self-Assessment (NCLEX-Style)

1. Signs more consistent with hypoxemia (vs. hypercapnia) — Select all that apply:

   • Cyanosis ★

   • Tachypnea ★

   • Paradoxical breathing ★

2. Selecting an $\text{O}_2$ device for acute hypoxemic ARF: Base the choice on patient condition & FiO2 needs (option d).

3. Earliest ARDS manifestations: Dyspnea & tachypnea (option a).

4. Evidence-based ARDS interventions — Select all that apply:

   • Prone positioning ★

   • Low tidal volume ventilation ★

   • Positive end-expiratory pressure ★

5. To limit volutrauma during mechanical ventilation: Use low tidal volume ventilation (option c).

Key Numeric / Formula Quick Reference

• Normal V/Q ratio: $1:1$

• Hypoxemic ARF diagnostic threshold: \text{PaO}_2 < 60\;\text{mmHg} on $\ge 60\%$ FiO2

• Hypercapnic ARF: \text{PaCO}_2 > 45\;\text{mmHg} with pH < 7.35

• ARDS severity marker: \text{PaO}2/\text{FiO}2 < 300 (refractory hypoxemia)

• Acceptable permissive hypercapnia in ARDS: $\text{PaCO}_2 \le 60\;\text{mmHg}$, pH > 7.25

• Low VT ventilation: $4–6\;\text{mL\,kg}^{-1}$ PBW

• Target MAP: $\ge 65\;\text{mmHg}$

Ethical & Practical Considerations

• High mortality & long-term disability → early family meetings, goals-of-care discussions, advance directives

• Sedation & paralytics demand vigilant neuro assessments and DVT/VAP prophylaxis; daily “sedation vacations” if feasible

• ECMO resource allocation requires ethical triage in surge settings (pandemic / mass casualty)

• Psychosocial follow-up: post-ICU syndrome screening, referral to counseling, pulmonary rehab programs

Connections to Core Physiology & Prior Learning

• Concepts of V/Q matching, diffusion, and ventilatory drive bridge directly back to foundational respiratory pathophysiology

• ARDS exemplifies systemic inflammatory response and “cytokine storm” previously discussed in sepsis lectures

• Conservative fluid management mirrors principles covered in cardiogenic vs. non-cardiogenic pulmonary edema sessions